[Skip to Navigation]
May 1999

Antipruritic Potency of Serotonin Type 3 (5-HT3) Receptor Antagonists—a Reply

Author Affiliations

Not Available

Arch Dermatol. 1999;135(5):600. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-5-dlt0599

In reply

We appreciate the interest of Weisshaar et al in our case report.1 The answers to points they raise are as follows:

We found the account of the commentators' previous experimental work and complementary case report very interesting. Our case report demonstrates that ondansetron has provided a sustained clinical benefit without adverse effects for a difficult management problem of localized pruritus and is worth considering in such situations.

Add or change institution